{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:41:37Z","timestamp":1790023297407,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10810"],"award-info":[{"award-number":["17K10810"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K09183"],"award-info":[{"award-number":["20K09183"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.lfs.2021.119847","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T01:47:05Z","timestamp":1626659225000},"page":"119847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis"],"prefix":"10.1016","volume":"282","author":[{"given":"Keitaro","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Endou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Chida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119847_bb0005","first-page":"2762","article-title":"Genome-wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes","volume":"41","author":"Bi","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2021.119847_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lfs.2021.119847_bb0015","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2018.10.018","article-title":"Systemic treatments for thymoma and thymic carcinoma: a systematic review","volume":"126","author":"Berghmans","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lfs.2021.119847_bb0025","doi-asserted-by":"crossref","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","article-title":"Chemotherapy definitions and policies for thymic malignancies","volume":"6","author":"Girard","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","article-title":"ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting","volume":"9","author":"Marx","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0035","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 world health organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0045","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.119847_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/imcb.12218","article-title":"Itaconate: an emerging determinant of inflammation in activated macrophages","volume":"97","author":"Yu","year":"2019","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119847_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119847_bb0060","doi-asserted-by":"crossref","first-page":"16225","DOI":"10.1074\/jbc.M113.454538","article-title":"Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119847_bb0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2021.119847_bb0070","doi-asserted-by":"crossref","first-page":"14274","DOI":"10.1074\/jbc.M115.685792","article-title":"Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels","volume":"291","author":"Cordes","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119847_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","article-title":"Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6-ATF3 inflammatory axis","volume":"556","author":"Bambouskova","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119847_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.alit.2019.12.006","article-title":"L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness","volume":"69","author":"Kaminuma","year":"2020","journal-title":"Allergol. Int."},{"key":"10.1016\/j.lfs.2021.119847_bb0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119847_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.lungcan.2015.06.014","article-title":"Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy","volume":"89","author":"Kossai","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lfs.2021.119847_bb0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0100","doi-asserted-by":"crossref","first-page":"890","DOI":"10.18632\/oncotarget.1015","article-title":"Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses","volume":"4","author":"Wheler","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2021.119847_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","article-title":"Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the akt-mTOR signaling pathway","volume":"358","author":"Zhao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2021.119847_bb0110","first-page":"224","article-title":"Targeting lactate dehydrogenase-a promotes docetaxel-induced cytotoxicity predominantly in castration-resistant prostate cancer cells","volume":"42","author":"Muramatsu","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2021.119847_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jphs.2016.07.006","article-title":"LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells","volume":"132","author":"Hayashi","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2021.119847_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","article-title":"L-type amino acid transporter 1 inhibitors inhibit tumor cell growth","volume":"101","author":"Oda","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2021.119847_bb0125","first-page":"727","article-title":"Biological role of metabolic reprogramming of cancer cells during epithelial-mesenchymal transition","volume":"41","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2021.119847_bb0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4251\/wjgo.v11.i10.768","article-title":"Cancer-specific metabolism: promising approaches for colorectal cancer treatment","volume":"11","author":"Jeong","year":"2019","journal-title":"World J Gastrointest Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0135","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)","volume":"273","author":"Kanai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119847_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/all.14019","article-title":"LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation","volume":"75","author":"Hayashi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.lfs.2021.119847_bb0145","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10637-020-00924-3","article-title":"First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors","volume":"38","author":"Okano","year":"2020","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.lfs.2021.119847_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/imcb.12316","article-title":"Dimethyl itaconate protects against fungal keratitis by activating the Nrf2\/HO-1 signaling pathway","volume":"98","author":"Gu","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119847_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11864-017-0495-8","article-title":"Novel agents in the treatment of thymic malignancies","volume":"18","author":"Merveilleux du Vignaux","year":"2017","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.lfs.2021.119847_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117110","article-title":"Fluvastatin is effective against thymic carcinoma","volume":"240","author":"Hayashi","year":"2020","journal-title":"Life Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521008341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521008341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:52:50Z","timestamp":1758401570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521008341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"alternative-id":["S0024320521008341"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119847","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119847"}}